Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Trelleborg – page 20

453 clinical trials in Trelleborg, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Trelleborg at a glance
453
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

453 trials in Trelleborg

Open in trial search

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Region Skane

Diabetic foot

Not yet recruiting

Study Comparing Propylene Glycol and Urea Creams for Treating Dry Feet in People with Diabetes

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Propylene Glycol
  • Sponsor:Malmoe Universitet

Dementia Alzheimer's type

Not yet recruiting

Study on JNJ-64042056 for Preclinical Alzheimer's Disease in Patients

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:JNJ-64042056
  • Sponsor:Janssen Cilag International

Abortion induced

Not yet recruiting

Study on Immediate vs. Delayed Insertion of Levonorgestrel IUD for Women After Medical Abortion

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Levonorgestrel
  • Sponsor:Karolinska Institutet

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dulaglutide
  • Sponsor:Eli Lilly & Co.

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Olpasiran
  • Sponsor:Amgen Inc.

Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer's Disease over 72 weeks

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:VHB937
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Lyme disease

Not recruiting

Study on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
  • Substances:Lip-D1B2B
  • Sponsor:Pfizer Inc.

Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Major depression

Not recruiting

Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Seltorexant
  • Sponsor:Janssen Cilag International

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Trelleborg

What the registry says about research in the country

01 Analytical and Diagnostic Research

Clinical trial activity in Trelleborg includes analytical and diagnostic research focused on better understanding treatment response and patient outcomes in everyday practice.

  • Assessment of symptom improvement in allergic rhinitis due to dog allergy
  • Monitoring clinical response to allergen-specific vaccination
  • Evaluation of outcome measures used to track effectiveness in routine care

These studies aim to improve how clinicians identify benefit and measure changes in patients over time.

02 Allergy and Immune System Diseases

One major focus is immune system diseases, especially allergic rhinitis due to dog allergy, with research designed to test whether targeted allergy treatment can reduce symptoms and improve quality of life.

  • Dog allergy and related nasal symptoms
  • Allergen immunotherapy in real-world Swedish practice
  • Long-term relief of allergy-related discomfort

This work explores the effectiveness of a new approach for helping patients manage persistent allergy symptoms.

03 Musculoskeletal Diseases

Another key area is musculoskeletal diseases, particularly research linked to hip arthroplasty and prevention of prosthetic joint infection.

  • Prosthetic Joint Infection after joint replacement
  • Strategies to lower infection risk following hip replacement
  • Support for safer recovery in orthopedic care

The goal is to evaluate whether infection-preventing bone graft treatment can improve outcomes after surgery.

04 Bacterial Infections and Surgical Procedures

Research in bacterial infections and surgical procedures is centered on preventing post-operative complications and improving the success of orthopedic treatment.

  • Prevention of infection in bone graft use
  • Protection against bacteria-related complications after surgery
  • Testing a treatment approach designed to support surgical recovery

These trials help clarify whether infection-focused interventions can make operative care safer and more effective.

05 Musculoskeletal and Neural Physiological Phenomena

The local research profile also reflects interest in musculoskeletal and neural physiological phenomena, with clinical studies examining how the body responds to allergy treatment and orthopedic interventions.

  • Changes in symptoms and function over time
  • Patient response after allergen treatment
  • Recovery patterns following joint replacement

In Trelleborg, these studies aim to connect physiological changes with practical benefits for patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.